Literature DB >> 30762203

Association between ATT and Hepatotoxicity: Food for Thought.

Joseph L Mathew1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30762203     DOI： 10.1007/s12098-019-02899-3

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN： 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  15 in total

1.  Revised Antituberculosis Drug Doses and Hepatotoxicity in HIV Negative Children.

Authors:  C K Indumathi; Aruna Sethuraman; Saurav Jain; Savita Krishnamurthy
Journal:  Indian J Pediatr       Date:  2018-12-04       Impact factor: 1.967

2.  Serious Adverse Reactions From Anti-tuberculosis Drugs Among 599 Children Hospitalized for Tuberculosis.

Authors:  Yiyuan Li; Yu Zhu; Qin Zhong; Xiaojun Zhang; Min Shu; Chaomin Wan
Journal:  Pediatr Infect Dis J       Date:  2017-08       Impact factor: 2.129

3.  Genetic polymorphisms of CYP2E1 and GSTM1 loci and susceptibility to anti-tuberculosis drug-induced hepatotoxicity.

Authors:  S K Sharma; B K Jha; A Sharma; V Sreenivas; V Upadhyay; C Jaisinghani; R Singla; H K Mishra; M Soneja
Journal:  Int J Tuberc Lung Dis       Date:  2014-05       Impact factor: 2.373

4.  Risk factors of isoniazid-induced hepatotoxicity in Tunisian tuberculosis patients.

Authors:  N Ben Fredj; R Gam; E Kerkni; A Chaabane; Z Chadly; N Boughattas; K Aouam
Journal:  Pharmacogenomics J       Date:  2016-04-19       Impact factor: 3.550

5.  Evaluation of risk factors for antituberculosis treatment induced hepatotoxicity.

Authors:  Rohit Singla; Surendra K Sharma; Alladi Mohan; Govind Makharia; V Sreenivas; Brajesh Jha; Sanjeev Kumar; Pawan Sarda; Sarman Singh
Journal:  Indian J Med Res       Date:  2010-07       Impact factor: 2.375

6.  A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis.

Authors:  Martin J Boeree; Andreas H Diacon; Rodney Dawson; Kim Narunsky; Jeannine du Bois; Amour Venter; Patrick P J Phillips; Stephen H Gillespie; Timothy D McHugh; Michael Hoelscher; Norbert Heinrich; Sunita Rehal; Dick van Soolingen; Jakko van Ingen; Cecile Magis-Escurra; David Burger; Georgette Plemper van Balen; Rob E Aarnoutse
Journal:  Am J Respir Crit Care Med       Date:  2015-05-01       Impact factor: 21.405

7.  NAT2 Genotypes in Moroccan Patients with Hepatotoxicity Due to Antituberculosis Drugs.

Authors:  Soukaina Guaoua; Ilham Ratbi; Omaima El Bouazzi; Sanaa Hammi; Amina Tebaa; Jamal Eddine Bourkadi; Rachida Soulaymani Bencheikh; Abdelaziz Sefiani
Journal:  Genet Test Mol Biomarkers       Date:  2016-08-19

8.  Effect of scheduled monitoring of liver function during anti-Tuberculosis treatment in a retrospective cohort in China.

Authors:  Shanshan Wu; Yinyin Xia; Xiaozhen Lv; Yuan Zhang; Shaowen Tang; Zhirong Yang; Dehua Tu; Peiyuan Deng; Shiming Cheng; Xiaomeng Wang; Yanli Yuan; Feiying Liu; Daiyu Hu; Siyan Zhan
Journal:  BMC Public Health       Date:  2012-06-19       Impact factor: 3.295

9.  Drug-induced hepatotoxicity of anti-tuberculosis drugs and their serum levels.

Authors:  Ina Jeong; Jong-Sun Park; Young-Jae Cho; Ho Il Yoon; Junghan Song; Choon-Taek Lee; Jae-Ho Lee
Journal:  J Korean Med Sci       Date:  2015-01-21       Impact factor: 2.153

10.  Liver toxicity associated with tuberculosis chemotherapy in the REMoxTB study.

Authors:  Conor Duncan Tweed; Genevieve Helen Wills; Angela M Crook; Rodney Dawson; Andreas H Diacon; Cheryl E Louw; Timothy D McHugh; Carl Mendel; Sarah Meredith; Lerato Mohapi; Michael E Murphy; Stephen Murray; Sara Murthy; Andrew J Nunn; Patrick P J Phillips; Kasha Singh; M Spigelman; S H Gillespie
Journal:  BMC Med       Date:  2018-03-28       Impact factor: 8.775
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.